We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · December 29, 2020

Secukinumab Shows High and Sustained Efficacy in Nail Psoriasis

The British Journal of Dermatology


Additional Info

The British Journal of Dermatology
Secukinumab Shows High and Sustained Efficacy in Nail Psoriasis: 2.5-Year Results From the Randomized Placebo-Controlled TRANSFIGURE Study
Br J Dermatol 2020 Jun 01;[EPub Ahead of Print], K Reich, J Sullivan, P Arenberger, S Jazayeri, U Mrowietz, M Augustin, B Elewski, R You, P Regnault, JA Frueh

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading